Biomedical subjects

T Kida

Publications and source records attributed to T Kida.

At least 91 records · Page 5Linked to original sources

PubMed1983

Clinical studies on diverticular disease of the colon.

In 12,505 patients who received barium enemas during the past 14 days, 979 cases (7.8%) of diverticular disease of the colon (DDC) were found. The incidence of DDC increased with age; 2.2% of the patients were below age 29 and 14.3% were over 70 years old. The sex distribution was 584 males and 395 females. 76.1% had diverticula in the right-side colon, 12.9% in the left-side colon, and 11.0% in both sides. All patients below age 29 had the right-side colon type, while 44% of those aged 70 or more did. On the other hand, the left-side colon type and both-sides colon type were found only in patients over 30 years old, and constituted a majority in those of 70 years old or more. The main symptoms and signs were: disturbances in bowel habits 50.7%, abdominal pain 48.1%, abdominal distension and/or discomfort 41.5%, occult blood 25.2% and melena 5.8%. Therefore, DDC is clinically becoming an important disease in recent years in Japan as well as in Western countries.

Adolescent↗

PubMed1983

The fermentation, isolation and characterization of a macromolecular peptide antibiotic: AN-3.

A new macromolecular peptide antibiotic, named AN-3, was isolated from the culture broth of Streptomyces albulus. From 19 liters of culture broth containing AN-3 with 90 units/ml activity, a 400 mg sample with a specific activity of 109 units/mg was obtained. Purified AN-3 gave a single band on polyacrylamide gel electrophoresis. AN-3 was a basic polypeptide with a molecular weight of 12,000 approximately 12,500 and an isoelectric point of pH 7.6. It showed a peak of absorption at 280 nm and seemed to have no nonprotein chromophoric component. It was soluble in water but insoluble in ethanol, butanol and acetone, and was stable at pH 4 approximately 9 but unstable at pH2. AN-3 had no antibacterial activity against Gram-positive and Gram-negative bacteria so far as tested. But, it showed a strong inhibitory effect on a macromolecule permeable mutant of Escherichia coli. It was not mutagenic. It appeared to inhibit synthesis of DNA and RNA without affecting DNA itself. It also inhibited the in vitro cell growth of L1210 and its ED50 was 5 micrograms/ml. AN-3 had antitumor activity against Lewis lung carcinoma in mouse in vivo.

Animals↗

PubMed1983

New streptothricin-group antibiotics, AN-201 I and II. Screening, fermentation, isolation, structure and biological activity.

Two streptothricin-group antibiotics, AN-201 I and II, were newly discovered and isolated from the culture broth of Streptomyces nojiriensis C-13. These antibiotics were purified by IRC-50 (H+) and CM-Sephadex C-50 chromatography, and paper electrophoresis. Structural analysis of AN-201 I and II showed that they were N beta-acetylated derivatives of streptothricin E and D, respectively. They had antibacterial activities against several strains of Escherichia coli, Bacillus subtilis, Micrococcus luteus and Staphylococcus aureus, and showed a strong selective cytotoxic effect on 3T3 cells transformed with SV-40 as compared with their normal cells in a test system in vitro as well as in vivo.

Animals↗

PubMed1982